Bringing the fundamentals into focus…
Back to Omeros Corporation
How Omeros Corporation stacks up
OMER · against 452 other Healthcare companies of similar size
Valuation
71/ 100
Above the middle of the pack.
Ranked #155 of 453 · scores higher than 66% of peers
Bars: peers in each 10-point band of the valuation score49 peers with a valuation score of 70–79, including OMER · Click a bar to see the companies
Why valuation scores 71?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its earnings yield, which is stronger than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. EBITDA yield: -5.8% vs peer median 4.0%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -5.2% vs peer median 0.0%
- higher earnings for the price paid: stronger than 93% of peers. Earnings yield: 9.4% vs peer median 1.5%
Metric by metric
Position: dot = OMER, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | OMER | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 443 reported | 9.0% | 1.5% | 95% | 30% | |
| EBITDA yieldHigher is better · 458 reported | -4.8% | 4.5% | 20% | 50% | |
| Free cash flow yieldHigher is better · 202 reported | -5.2% | -1.1% | 36% | 20% | |
| Book yieldHigher is better · 448 reported | -3.9% | 40.4% | 2% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around OMERScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score